-+ 0.00%
-+ 0.00%
-+ 0.00%

Insight Molecular Diagnostics: Q3 Earnings Snapshot

Barchart·11/16/2026 16:46:57
Listen to the news

NASHVILLE, Tenn. (AP) — NASHVILLE, Tenn. (AP) — Insight Molecular Diagnostics Inc. (IMDX) on Monday reported a loss of $3.6 million in its third quarter.

On a per-share basis, the Nashville, Tennessee-based company said it had a loss of 10 cents. Losses, adjusted for non-recurring gains, came to 19 cents per share.

The cancer diagnostic test developer posted revenue of $559,000 in the period.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IMDX at https://www.zacks.com/ap/IMDX